Depression. Other depressive episodes
Conditions
Interventions
Intervention 1: Intervention group: Tablet mirtazapine 7.5 mg daily for one week and then 15 mg daily for 11 weeks. Intervention 2: Control group: Tablet sertraline 50 mg daily for one week and then 1
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Age of 18 to 5 years Undergoing hemodialysis for at least 6 months Being literate Suffering from depression
Exclusion criteria
Exclusion criteria: Pregnancy or breastfeeding Receiving anti-depressant and anti-anxiety medication in the last 3 months Liver failure Use of drugs or alcohol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression score. Timepoint: In weeks 4, 8, and 12 after the treatment. Method of measurement: Using the Beck Inventory Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life score. Timepoint: After week 12. Method of measurement: Using Global Quality of Life Scale.;Serum albumin level. Timepoint: After week 12. Method of measurement: By using laboratory test.;Percentage of weight gain. Timepoint: After week 12. Method of measurement: By using weights. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShadieh Shariati
Hamedan University of Medical Sciences
Outcome results
None listed